FDA Adverse Event Injury Summary report: N

MRS FEM ROT HNGE LFT 65MM BOD

MDR report key: 3924408 · Received July 9, 2014

Report

Report Number
0002249697-2014-02595
Event Type
Injury
Date Received
July 9, 2014
Date of Event
April 23, 2014
Report Date
June 12, 2014
Manufacturer
STRYKER ORTHOPAEDICS-MAHWAH
Product Code
KRO
PMA / PMN Number
K972401
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MA, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

A MATERIAL ANALYSIS WAS PERFORMED ON THE STEM AND CONCLUDED THAT THE FEMORAL STEM FRACTURED IN FATIGUE THE EVENT COULD NOT BE CONFIRMED NOR THE ROOT CAUSE OF THE REPORTED REVISION SURGERY DETERMINED DUE TO THE MINIMAL INFORMATION RECEIVED. THE CLINICAL INDICATION FOR THE REVISION WAS NOT PROVIDED. NO FURTHER INVESTIGATION FOR THIS EVENT IS POSSIBLE AT THIS TIME AS NO DEVICES AND INSUFFICIENT INFORMATION WAS RECEIVED BY STRYKER ORTHOPAEDICS. IF DEVICES AND / OR ADDITIONAL INFORMATION BECOME AVAILABLE, THIS INVESTIGATION WILL BE REOPENED.

Additional Manufacturer Narrative · 1

THE OTHER DEVICES LISTED IN THIS REPORT: CAT. NO.: 2481-3-080, MRS FEM W/MALE-FE TAPER 80 BD, LOT CODE: BSIRC; CAT. NO: UNK, UNKNOWN TIBIAL ROTATING COMPONENT, LOT CODE: UNK ; CAT. NO: UNK, UNKNOWN AXLE, LOT CODE: UNK; CAT. NO: UNK, UNKNOWN CEMENTED STEM, LOT CODE: UNK; CAT. NO: UNK, UNKNOWN BUMPER, LOT CODE: UNK; CAT. NO: UNK, UNKNOWN FEMORAL BUSHINGS, LOT CODE: UNK. AT THIS TIME, IT CANNOT BE DETERMINED IF THESE DEVICES MAY HAVE CAUSED OR CONTRIBUTED TO THE PATIENT¿S EXPERIENCE. A SUPPLEMENTAL REPORT WILL BE SUBMITTED UPON COMPLETION OF THE INVESTIGATION.

Description of Event or Problem · 1

IT WAS REPORTED THAT PATIENT WAS REVISED ON (B)(6) 2014 DUE TO UNKNOWN REASON.

Description of Event or Problem · 1

IT WAS REPORTED THAT PATIENT WAS REVISED ON (B)(6) 2014 DUE TO UNKNOWN REASON.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
401039 MRS FEM ROT HNGE LFT 65MM BOD IMPLANT KRO STRYKER ORTHOPAEDICS-MAHWAH UNKNOWN

Patients

Seq Age Sex Outcome Treatment
1 59 YR Required Intervention